Science News

Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.

A new interesting article has been published in Hormones (Athens). 2018 Sep 25. doi: 10.1007/s42000-018-0069-6. Review and titled:

Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.

Authors of this article are:
Anastasilakis DA Makras P Polyzos SA Anastasilakis AD; Part of the COMBO ENDO TEAM: 0.

A summary of the article is shown below:
Asymptomatic primary hyperparathyroidism (PHPT) and the new variant of PHPT, normocalcemic PHPT, are considered by many physicians as mild, innocuous forms of disease, requiring nothing more than monitoring. Although this may be true in some cases in which the disease does not progress or cause complications, deterioration with more or less severe manifestations may occur. In the present review, we discuss the existing evidence of both the classic (skeletal and renal) and non-classic (cardiovascular, gastrointestinal, and psychiatric) features that have been attributed to asymptomatic and normocalcemic PHPT and the treatment effect on them.

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as: Asymptomatic;Bone;Hyperparathyroidism;Normocalcemic;Renal.

Categories: Science News